HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums/Lanvin deal

This article was originally published in The Rose Sheet

Executive Summary

Inter Parfums' Paris-based subsidiary, Inter Parfums S.A., and Lanvin are negotiating a "long-term worldwide license agreement for the creation, development and distribution of fragrance lines under the Lanvin brand name," fragrance company announces June 3. Provisions of the deal would include "an upfront license fee, advertising expenditures and royalty payments" as well as the purchase of existing inventory, firm notes. Proposed transaction is contingent upon a formal agreement between the parties. Lanvin fragrance sales reached $33 mil. in 2003, Inter Parfums says. Planned agreement follows announcement by the French fashion company that it would license its fragrance business and focus on its core ready-to-wear collection due to a difficult economic situation (1"The Rose Sheet" April 12, 2004, In Brief)...

You may also be interested in...



Inter Parfums buys Lanvin brands

Fragrance firm's 72%-owned Paris subsidiary, Inter Parfums SA, has acquired the worldwide rights to Lanvin brand names and international trademarks listed under Class 3 - those associated with soaps, perfumery, essential oils, cosmetics and hair lotions - for roughly $29.7 mil. in cash, according to an Aug. 1 release. The two companies' licensing contract signed in June 2004 has been terminated (1"The Rose Sheet" June 7, 2004, In Brief). Under the new agreement, "Inter Parfums will also pay to Lanvin a sales-based fee for technical and creative assistance in new product development to be rendered by Lanvin in connection with the use of the Lanvin trademark through June 30, 2019." Lanvin has the right to repurchase the brands and trademarks in 2025. "Lanvin has quickly become the second-largest brand in our prestige fragrance portfolio," Inter Parfums Chair and CEO Jean Madar notes. "Our decision to buy Lanvin Perfumes is indicative of our long-term commitment to growing the Lanvin fragrance business." Lanvin brands include Eclat d'Arpège, Rumeur and Paul Smith...

Lanvin restructuring

Faced with "a deteriorated economic situation," French company announces plan to license its fragrance business in an effort to focus on its core luxury ready-to-wear collections for men and women. Restructuring program is aimed at reducing costs 25%, and will also include the elimination of 65 jobs and Lanvin's watchmaking business. In 2003, the company posted a net loss of $26.8 mil. (€1=$1.21). Lanvin fashion and fragrance brand was purchased from L'Oréal by Taiwanese investor Shaw-Lan Wang and a group of private French investors in 2001...

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel